Our Team

Dr. Vinayaka leads the Research & Development and Platform Integration divisions at Achira Labs, bringing over 18 years of pioneering research experience to the organization’s leadership team. Since January 2024, he has directed the innovation of advanced analytical methods, overseeing the seamless convergence of molecular biology and immunoassays—including ELISA, CLIA, and FLIA within stringent Quality Management Systems (QMS).

A globally recognized authority in Point-of-Care (POC) diagnostics, Dr. Vinayaka specializes in the architecture of next-generation diagnostic platforms. His work is defined by a multidisciplinary approach, integrating complex bioanalytical assays with high-fidelity optical detection modules to deliver clinical-grade accuracy in portable formats.

Core Competencies & Strategic Impact

• Platform Innovation: Expert in transferring sophisticated bioanalytical assays to proprietary POC platforms, ensuring rigorous validation and performance stability.
• Advanced Biosensor Design: Specialized in the development of multiplexed biosensors and the integration of optical detection systems, including fluorescence, luminescence, turbidimetry, and absorbance.
• Leadership & Collaboration: A proven track record in building high-performance scientific teams and fostering cross-functional synergy to drive end-to-end product innovation.

Distinguished Fellowships & Academic Excellence

Dr. Vinayaka’s career is underpinned by prestigious international recognition, reflecting his contribution to the global scientific community. His accolades include:

• Marie Curie Fellowship (Technical University of Denmark)
• CSIR-Nehru Postdoctoral Fellowship (IMTECH, Chandigarh)
• Senior Research Fellowship (CFTRI, Mysore)

His leadership ensures that Achira Labs continues to push the boundaries of diagnostic technology, translating complex laboratory science into robust, real-world medical solutions.

Komal is a results-driven R&D leader with over nine years of specialized expertise in the design, development, and commercialization of advanced In-Vitro Diagnostics (IVD). At Achira Labs, she spearheads the innovation of high-performance Lateral Flow Assays (LFAs), transforming rapid testing into a tool of quantitative precision for global healthcare markets.

Throughout her career, Komal has been at the forefront of diagnostic evolution, moving beyond qualitative "yes/no" results to deliver sophisticated, high-sensitivity diagnostic platforms. Her work spans a broad spectrum of clinical applications, including critical biomarkers for acute kidney injury (NGAL) and systemic inflammation (CRP), as well as high-impact infectious diseases such as Malaria, HIV, and COVID-19.

Technological Breakthroughs & Innovation

• Nanotechnology Advancement: Developed proprietary gold nanoshell particles that achieved a revolutionary 100-fold increase in assay sensitivity, pushing the boundaries of detection limits for rapid diagnostics.
• Digital Health Integration: Co-inventor of a patented, smartphone-based reader technology that enables quantitative, lab-grade results on standard LFA platforms—an essential step in the democratization of precision diagnostics.
• Full-Cycle Product Development: Leads the end-to-end journey from foundational molecular design to large-scale commercialization, ensuring that innovative concepts are translated into reliable, market-ready diagnostic tools.
• Clinical Impact: Dedicated to the development of assays that provide immediate, actionable data, significantly reducing the time-to-treatment in resource-limited and point-of-care settings.

Komal’s technical expertise in biochemistry and nanotechnology, combined with her focus on digital connectivity, ensures that Achira Labs remains a leader in the next generation of smart, high-sensitivity rapid diagnostics.

Dr. Bhavna Goyal leads the Clinical Studies division at Achira Labs, where she oversees the rigorous validation of diagnostic platforms and medical devices. With over 15 years of research experience—including nearly a decade dedicated to the diagnostics industry—Dr. Goyal is the primary architect of Achira’s clinical evidence strategies, ensuring that every product meets the highest benchmarks of accuracy, reliability, and global regulatory compliance.

A scientist of international standing, Dr. Goyal holds a Ph.D. in Life Sciences from the International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi. She is responsible for the vital transition of diagnostic innovations from the laboratory to real-world clinical application.

Clinical Leadership & Strategic Alliances

• Validation & Regulatory Governance: Directs the end-to-end clinical validation process, ensuring that diagnostic performance meets stringent regulatory mandates and clinical efficacy standards.
• Institutional Partnerships: Manages strategic collaborations with NABL-accredited laboratories and premier hospitals, overseeing the legal and ethical frameworks of MOUs, NDAs, and Institutional Ethics Committee (IEC) approvals.
• Clinical Sample Stewardship: Leads the acquisition of clinical biosamples and manages feasibility assessments to support internal validation and pilot studies.
• Multiplex Assay Innovation: Possesses deep technical expertise in developing multiplexed assays for hormone panels, infectious diseases, and renal biomarkers.
• Evidence-Based Excellence: Drives a culture of scientific rigor, supported by her extensive background in advanced data analysis, biochemistry, and molecular biology, as evidenced by her portfolio of peer-reviewed publications and international grants.

Dr. Goyal’s commitment to scientific integrity ensures that Achira Labs’ solutions are not only innovative but are clinically proven tools ready to enhance patient outcomes in diverse healthcare settings worldwide.

Dr. S. Christy Rosaline is a distinguished manager at Achira Labs, where she spearheads the development and clinical validation of next-generation diagnostic solutions. With a focus on high-acuity needs—including rapid UTI detection, advanced antibiotic susceptibility testing (AST), and precision lateral flow assays—Dr. Rosaline ensures that scientific innovation meets the rigorous demands of modern medicine.

Combining deep technical acumen with a commitment to quality, she leads the end-to-end lifecycle of diagnostic R&D, from initial product design to stringent regulatory compliance and pilot launch. Her work is central to Achira’s mission of delivering diagnostic accuracy at the point of care.

Areas of Expertise

• Translational R&D: Over six years of experience in microbiology, molecular biology, and biosensor technology, successfully moving products from benchtop concepts to clinical applications.
• Clinical Leadership: Expert oversight of multi-platform clinical trials for infectious diseases, ensuring robust data integrity and alignment with global healthcare standards.
• Regulatory & Quality Excellence: Dedicated focus on quality control (QC) frameworks and regulatory pathways to ensure patient safety and product reliability.
• Academic Distinction: A Ph.D. in Biotechnology and a recipient of multiple prestigious ICMR (Indian Council of Medical Research) fellowships, underscoring her contributions to the scientific community.

Sid serves as the Head of Program Management at Achira Labs, where he orchestrates the complex lifecycle of medical device development from initial concept to global market delivery. With an engineering foundation and over seven years of specialized experience in high-stakes instrumentation and diagnostics, he acts as the strategic nexus between R&D, Engineering, Operations, and Quality.

Sid is responsible for driving organizational momentum, ensuring that Achira’s ambitious technical roadmap is met with disciplined execution and rigorous governance. He specializes in creating the transparent workflows and robust data-integrity frameworks necessary to navigate the highly regulated diagnostic landscape with both agility and precision.

Strategic Oversight & Program Governance

• Cross-Functional Integration: Acts as the primary bridge between multidisciplinary teams, harmonizing scientific breakthroughs with engineering realities and operational scale.
• Regulatory-Aligned Development: Expertly navigates the integration of quality systems and regulatory requirements within the development pipeline, ensuring that speed-to-market never compromises compliance.
• Operational Excellence: Passionate about the design of smarter governance systems that foster a culture of accountability, decision-making clarity, and sustained momentum.
• Instrumentation & Technical Expertise: Leverages a strong engineering background to oversee the technical requirements of diagnostic hardware, ensuring alignment with both clinical needs and manufacturing capabilities.
• Data Integrity & Risk Mitigation: Focuses on strengthening internal data frameworks to support audit readiness and reliable product performance, empowering teams to execute with confidence.

By establishing the frameworks that allow innovation to scale, Sid ensures that Achira Labs remains a reliable and efficient partner to healthcare providers and global distributors, delivering life-impacting diagnostic solutions with world-class precision.

Faisal is a seasoned leader with over nine years of cross-functional experience driving growth at the intersection of pharmaceutical innovation and medical diagnostics. As a key strategist at Achira Labs, he orchestrates the alignment of commercial objectives with scientific breakthroughs, overseeing the full product lifecycle—from foundational R&D to global market entry.

Throughout his career, Faisal has demonstrated a consistent ability to scale complex diagnostic portfolios and optimize business performance. His professional highlights include:

• Portfolio Excellence: Successfully spearheaded the launch of over 350 high-impact products across diverse therapeutic segments.
• Strategic Outreach: Established a premier "scientist-to-scientist" engagement framework, fostering deep institutional collaborations and technical synergy.
• Operational Leadership: Managed critical large-scale initiatives, including high-volume COVID-19 diagnostic operations and multidisciplinary team leadership.
• Technical Innovation: Driven advancements in recombinant antibody technologies and pioneered CRISPR-based validation protocols, resulting in significant intellectual property contributions and patent filings.

Faisal’s expertise ensures that Achira Labs remains at the forefront of the diagnostic industry, delivering precision-engineered solutions that address the evolving needs of global healthcare.

Raghavendra has been with Achira Labs since 2015, bringing a robust 18-year tenure in corporate finance, human capital management, and strategic operations. With a Postgraduate Diploma in Business Management (Finance) and a foundational career built within high-stakes export environments, he provides the fiscal and operational stewardship necessary to scale a leading-edge medical technology firm.

As a core member of the leadership team, Raghavendra is responsible for the architectural integrity of Achira’s business processes. He ensures that the company’s ambitious scientific goals are matched by rigorous financial planning and operational efficiency, facilitating a seamless bridge between innovation and market execution.

Strategic & Operational Leadership

• Financial Stewardship: Expertly manages accounts and financial strategy, optimizing resource allocation to support sustained long-term growth and organizational stability.
• Operational Optimization: Streamlines complex internal workflows and supply chain operations, leveraging his extensive background in export-house logistics to enhance corporate agility.
• Corporate Governance: Drives excellence across key business functions, maintaining the disciplined infrastructure required to navigate the dynamic and highly regulated medical diagnostic industry.

Raghavendra’s pragmatic leadership and dedication to operational effectiveness are fundamental to Achira Labs’ ability to deliver life-impactful technologies consistently and at scale. His commitment to cross-functional synergy empowers the organization to thrive in an increasingly complex global healthcare landscape.